Five-year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study.
Saliba F, Duvoux C, Dharancy S, Dumortier J, Calmus Y, Gugenheim J, Kamar N, Salamé E, Neau-Cransac M, Vanlemmens C, Durand F, Pageaux GP, Hardwigsen J, Benkhatar Y, Derquenne F, Conti F.
Saliba F, et al. Among authors: dumortier j.
Liver Int. 2022 Nov;42(11):2513-2523. doi: 10.1111/liv.15396. Epub 2022 Sep 1.
Liver Int. 2022.
PMID: 35962772
Free PMC article.